SUMMARY A trial comparing the efficacy of three different tetracyclines, each in two different dosage regimens, in the treatment of non-specific urethritis is described. There was a significant association between the retreatment rate and sexual intercourse. Age, race, duration of symptoms, previous infection, and indulgence in alcohol did not appear to influence the results whereas treatment of sexual contacts before resumption of sexual intercourse significantly reduced the retreatment rate. Single-dose treatment with doxycycline was shown to be ineffective. Treatment with doxycycline for seven days or triple tetracycline for seven days was less effective than triple tetracycline for 21 days or oxytetracyline for seven or 21 days, all of which gave the same success rate.
Introduction
Non-specific urethritis (NSU) is the commonest sexually transmitted disease in the United Kingdom (Department of Health and Social Security, 1976) and is very common in the USA (Wiesner, 1977) . There is evidence that this condition is also common in some of the developing areas of the world (Arya, 1972; Osoba, 1972) .
The optimum management of NSU continues to pose problems for the following reasons:
While tetracyclines are considered to be the moss effective remedy (Willcox, 1972) there is no agree ment on the preparation, the dose, and the duration of treatment. Over a score of treatment regimens of various tetracyclines have been tried. These range from a single dose of doxycycline (Masterton and Schofield, 1972) to a 21-day course of oxytetracycline (John, 1971) . All regimens have their advocates. The results of several studies are not strictly comparable because of the differences in the diagnostic criteria used. Very few studies have matched the outcome of treatment with variables of severity and duration of symptoms, past history, consumption of alcohol, et cetera.
More recently C. trachomatis has been suggested as an important cause of nongonococcal urethritis (Holmes et al, 1975; Oriel et al, 1976) . If that is accepted, then a search should be made for the treatment regimens appropriate to Chlamydiapositive and Chlamydia-negative patients with urethritis. It is unlikely, however, that public health laboratories in this country or elsewhere will provide a service for routine Chlamydia isolation in the foreseeable future. Treatment of NSU, therefore, in most parts of the world will continue to be empirical. An ideal regimen for any area must be the one which has been proved to be highly effective locally, because of the possibility of strain differences as well as different aetiological agents as yet un-414 known, and takes into account the problems of cost and drug compliance.
Some of the points raised above prompted us to evaluate six drug regimens, including one of a single dose. The concept of a single-session regimen in the treatment of NSU is not new. Alergant (1964) found a combination of 05 g streptomycin intramuscularly and two tablets of 0 5 g sulphamethoxydiazine (Durenate) as good as the conventional five-day treatment used in those days. Mahony et al (1972) , using a single-session regimen comprising oral sulfametopyrazine (2 g) and intramuscular streptomycin (1g), obtained a cure rate of 82% after 10-14 days' follow up. Doxycycline, which is claimed to give higher and more prolonged serum and tissue concentrations than standard tetracyclines, had earlier been proved to be highly effective (93 3 % cure rate) in a single dose of 300 mg in the treatment of NSU (Masterton and Schofield, 1972) . This last regimen could obviously be a major breakthrough in the management of NSU. We, therefore, thought it necessary to reassess it.
The subsidiary aims of this study were to investigate the effects of the following factors on the outcome of treatment:
1 
Presence of urethral discharge
Urethral discharge was present at the first attendance in 54% (mucoid in 25% and purulent or mucopurulent in 29%). Over half of the remaining 46% who had no demonstrable urethral discharge at the first visit were reviewed with a full bladder (urine held overnight or for at least three hours), and a further total of 21-5 % were found to have a scanty, mucoid, urethral discharge. Table 1 shows the total number of patients retreated compared with the number followed up in respect of each regimen as well as, individually, the number of those retreated at three to four weeks and at five to 12 weeks. Table 2 shows the corresponding figures after those who admitted to sexual intercourse during the follow-up period have been excluded.
The retreatment rates for group 3, three to four weeks after the start of treatment, were very small (triple tetracycline, nil, and oxytetracycline 2-3-4-2%) (Tables 1 and 2 ). Doxycycline in a single dose of 300 mg gave very high retreatment rates (over 60%, whether or not those admitted having sexual intercourse are included or excluded). This observation caused considerable concern and the single-dose regimen of doxycycline was immediately abandoned. This rate was significantly higher than that for any of the five remaining regimens whether those who admitted to sexual intercourse are included or excluded (P<0 001 in each case).
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As regards the retreatment rates for the other regimens, the difference between the retreatment rates for triple tetracycline (seven-day regimen) and triple tetracycline (21-day regimen) was significant (t,2 4 50: P<0 05). The differences between the remaining retreatment rates were not significant. If all those who admitted sexual intercourse, however, were excluded ( This difference was significant (x12 15 607; P<0 001). (Table 4) . Eleven female sexual contacts of the regimen) (x12 6-076; P<0-02), and triple tetracyline men given the single-dose of doxycycline, for whom (21-day regimen) (x127602; P<002). In group 1, the sexual intercourse had no bearing on the retreatnumber who had had sexual intercourse was very ment rate, have been excluded from Table 4 . Of the small and many of the retreatments (20 out of 28) 48 men who denied having had sexual intercourse had been given within the first three weeks, by during the follow-up period, 18 (37%) were rewhich time only three patients had had sexual treated compared with three out of 10 (33 %) who intercourse. admitted to sexual intercourse using a sheath and Further evidence of the effect of sexual inter-30 (55%) of the 54 who had had unprotected intercourse, as well as the effect of treatment of female course. The differences were not significant, but sexual contacts on the retreatment rate of men, was some patients may have been unreliable witnesses. obtained from the histories and clinical details Comparisons among those who admitted to un-(diagnosis and treatment) of the female contacts who protected sexual intercourse, therefore, might be attended the clinics at the Liverpool Royal Infirmary. more valid. Thus, of those who had unprotected After 32 female contacts of men who defaulted sexual intercourse, only six (25 %) of the 24 whose had been excluded, details of 123 women were an-contacts had received treatment before further alysed against each treatment regimen administered sexual intercourse were retreated compared with to men. Fifty three of the contacts were wives, and 24 (80 %) of 30 whose contacts were either treated EFFECT OF ALCOHOL AND OTHER FACTORS ON THE OUTCOME OF TREATMENT Alcohol Three hundred and sixty-five (64 9%) out of 562 patients followed up had resumed drinking alcohol during the period of surveillance. Of these, 232 (63 7% of 365) had done so within three weeks of starting treatment.
Of the 169 who had had unprotected sexual intercourse, 161 (95%) had also drunk alcohol as opposed to 164 (470% of 349) who had abstained from sexual intercourse. This difference was highly significant (xZ2 111 -456; p<0.0001). Of the 44 who had sexual intercourse using a sheath, only four had abstained from alcohol. Alcohol and intercourse, therefore do seem to go together. The effect of alcohol on the outcome of treatment among those who had had sexual intercourse cannot be assessed, since over 95% had drunk alcohol. Nevertheless, of the eight who had not drunk alcohol and had unprotected sex, three were retreated; and of the four who claimed to have had intercourse using a sheath one was retreated.
The effect of alcohol on the outcome of treatment may, however, be assessed among the remaining 349, who, as far as is known, had not had sexual intercourse (Table 5) . Thus, of the 272 who were not retreated, 131 (48 *2 %) had taken alcohol compared with 33 (43% of 77) who were retreated-that is, more of those who were not retreated had consumed alcohol-but the difference was not significant. Whether the patient started to drink within or after three weeks of starting treatment did not seem to make much difference, the retreatment rates being 21 % and 18 % respectively. As regards the individual treatment regimens, no clearcut pattern emerged.
Other factors Factors such as age, race, past history of NSU and duration of symptoms did not seem to have any influence on the retreatment rate. There was, however, a greater tendency for retreatment in those patients who had more severe symptoms (dysuria plus urethral discharge) or a frankly purulent urethral discharge. But the differences were not significant.
Discussion
Doxycycline in a single dose of 300 mg was followed by the highest retreatment rate. This result was no better than the 'cure' rate of 34% with a placebo (Fowler, 1970) . Masterton and Schofield (1972) claimed to have achieved a 'cure' rate of 933 %. The reason for this enormous difference in response is not clear. We had to abandon the doxycycline single-dose regimen after only 58 patients had been treated. Many of these patients remained symptomatic or had a symptomatic relapse with evidence of urethritis within one to two weeks after receiving the single dose. We consider this high failure rate a result of suboptimal dose and duration. The retreatment rate with this regimen was not influenced by sexual intercourse. Whether these patients continue to remain infectious remains to be determined. The clinical severity of the relapse in most cases suggested they would be. In the trial of Masterton and Schofield (1972) 'sixteen patients vomited and eight were nauseated out of 156 patients given vibramycin capsules'. Later they say, 'the incidence of side effects is low'. Their figures of side effects certainly cannot be equated with a low Masterton and Schofield (1972) found helpful in the control of nausea and vomiting).
Among seven-day regimens oxytetracycline for seven days gave the lowest retreatment rate. Differences in the retreatment rates with the three sevenday regimens in this survey were not, however, significant. Willcox (1972) reported a failure rate of 28 -6 % with triple tetracycline, one tablet twice daily for six days, compared with 30% in this study after seven days' treatment. Doxycycline for seven days gave equally high failure rates. Lassus et al (1971) , using doxycycline in a similar dosage but for only five days, obtained a 'cure' rate of over 93 % after a follow up of 14 to 21 days. The corresponding rate after seven days' treatment in our study was 85 9 %.
Although oxytetracycline for 21 days gave better results than any of the seven-day regimens, especially after those who had admitted sexual intercourse during surveillance had been excluded, the differences were not significant. Thus an increase in the duration of oxytetracycline treatment to 21 days did not result in any significant advantage over oxytetracycline given for seven days, as noted earlier by Helmy and Fowler (1975) . Triple tetracycline for 21 days in this study, however, gave significantly better results than triple tetracycline for seven days whether in respect of all cases followed up or after those who had sexual intercourse during surveillance had been excluded. Triple tetracyline for 21 days also gave significantly better results than doxycycline for seven days after those who had sexual intercourse had been excluded (X12 6-796; P<0-01). Our 15% retreatment rate with triple tetracycline 300 mg twice daily for 21 days was better than the 24 % rate reported by Helmy and Fowler (1975) who used the same dose three times a day for three weeks. Thus it may be concluded that doxycycline in a single dose has no place in the treatment of NSU. Triple tetracycline for seven days and doxycycline for seven days are also better avoided. There is no difference in efficacy between oxytetracycline for 21 days and triple tetracycline for 21 days, except the cost and the convenience. Triple tetracycline is more expensive but its twice-daily dosage is more convenient. Oxytetracycline for seven days compared favourably with both the 21-day regimens. Perhaps two weeks' treatment might be nearer the optimum duration.
Prolonged courses of tetracyclines have disadvantages. Firstly, they have no application in most parts of the developing countries except in only a few selected cases. Secondly, they have the potential to alter the bowel flora with the emergence of resistant micro-organisms. Fowler (1970) suggested the recurrences to be relapses rather than reinfections. Handsfield et al (1976) , who studied chlamydial infections in men and women, considered the later recurrences to be reinfections and suggested some of the early recurrences could also be attributed to reinfection by an organism with a shorter incubation period. In this study, of the 90 patients retreated after five weeks (almost all of them being recurrences) 64 were associated with sexual intercourse compared with only 11 of the 62 retreated at three to four weeks. This significant association between retreatment and sexual intercourse suggests reinfection. Preliminary observations in relation to chlamydial infections show similar trends (Arya and Mallinson, unpublished report) . Whether the sexual intercourse took place with the same or different partner was not recorded in many cases. This whole aspect was studied in greater depth for the 112 men whose sexual contacts were examined and who were themselves followed up for a variable length of time. The retreatment rates in men were significantly lower if the female contact was treated before further sexual intercourse than if sexual intercourse took place before she was treated. Examination and treatment of sexual contacts are, therefore, as logical in this condition as in any other sexually transmitted disease.
Few people, if any, believe today that alcohol causes urethritis. Despite lack of supportive evidence it remains standard teaching that alcohol may delay the resolution of an established case (Harkness, 1950) or cause a relapse (Catterall, 1974) . Less than 2% of alcohol is excreted in the urine (Kalant, 1973) . Although a known gastric irritant, its effects on urethral mucosa is unknown. In this study alcohol did not seem to have an important bearing on the outcome of treatment. This finding, however, was biased by the fact that every patient was advised to abstain from alcohol for at least three weeks. Although this advice was ignored by many, it might have resulted in much smaller quantities than usual being consumed. This study does nevertheless indicate the need to investigate this factor more thoroughly. Alcohol may certainly promote sexual activity by lowering inhibitions. Supportive evidence for this was found in that 950% of those who had unprotected sexual intercourse during the follow-up period in this study had also drunk alcohol. This biological interaction of ethanol and man at behavioural level is universally accepted as a reason for advising patients to abstain from alcohol in the management of NSU.
